Nontoxic goitre/thyroid nodule


No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector

Filter registries None


diagram downward connector

Check pre-conditions, main-only, mode, ICD version None


diagram downward connector

Check minimum number of events None


diagram downward connector

Extra metadata

First used in FinnGen datafreeze DF7

Similar endpoints

List of similar endpoints to Nontoxic goitre/thyroid nodule based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 7587 6374 1213
Unadjusted prevalence (%) 2.46 3.67 0.90
Mean age at first event (years) 51.63 50.48 57.69


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.95 [0.73, 1.23] 6.8e-1 519
15 years 0.00 0.72 [0.57, 0.91] 6.3e-3 239
5 years 0.00 1.27 [0.98, 1.63] 7.0e-2 103
1 year 0.00 1.79 [1.18, 2.71] 6.4e-3 27

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: E4_NONTOXIC_THYROID – Nontoxic goitre/thyroid nodule
GWS hits:

Survival analyses between endpoints


before Nontoxic goitre/thyroid nodule
after Nontoxic goitre/thyroid nodule

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Nontoxic goitre/thyroid nodule